Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling

Amy R. Dwyer(University of Minnesota Medical Center), Carol A. Lange(University of Minnesota)
Molecular Cancer Research
November 10, 2020
Cited by 22


Related Papers